Ghost Tree Capital’s Satsuma Pharmaceuticals STSA Stock Holding History
Bought
Maintained
Sold
Other funds holding STSA
Ghost Tree Capital's STSA Position: Q2 2022 in Review
Ghost Tree Capital sold out of Satsuma Pharmaceuticals (STSA) in Q2 2022, closing a stake of 473,562 shares — an estimated $1.8M sold.
Ghost Tree Capital first reported a position in STSA in Q1 2020 and held it in 9 quarters. The position peaked at $9.8M in Q2 2020. 32 funds tracked by Wall St. Rank hold STSA as of Q2 2022.
- Ghost Tree Capital reported no remaining Satsuma Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Ghost Tree Capital sold 473,562 Satsuma Pharmaceuticals shares in Q2 2022, an estimated $1.8M.
- Ghost Tree Capital first reported a position in Satsuma Pharmaceuticals in Q1 2020 and held it in 9 quarters.
- Ghost Tree Capital's Satsuma Pharmaceuticals position peaked at $9.8M in Q2 2020.
- 32 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q2 2022.
Based on Ghost Tree Capital's 13F filing for Q2 2022, filed 15 Aug 2022.